Literature DB >> 19139212

High blood levels of chromogranin A in giant cell arteritis identify patients refractory to corticosteroid treatment.

G Di Comite, P Previtali, C M Rossi, G Dell'Antonio, P Rovere-Querini, L Praderio, L Dagna, A Corti, C Doglioni, A Maseri, M G Sabbadini, A A Manfredi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19139212     DOI： 10.1136/ard.2007.086587

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

Review 1.  Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis.

Authors:  N Maugeri; P Rovere-Querini; M Baldini; M G Sabbadini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2009-03-20       Impact factor: 4.330

Review 2.  Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers.

Authors:  Angelo Corti; Fabrizio Marcucci; Tiziana Bachetti
Journal:  Pflugers Arch       Date:  2017-10-10       Impact factor: 3.657

3.  A new chromogranin A-dependent angiogenic switch activated by thrombin.

Authors:  Luca Crippa; Mimma Bianco; Barbara Colombo; Anna M Gasparri; Elisabetta Ferrero; Y Peng Loh; Flavio Curnis; Angelo Corti
Journal:  Blood       Date:  2012-11-27       Impact factor: 22.113

Review 4.  Disruption of a Regulatory Network Consisting of Neutrophils and Platelets Fosters Persisting Inflammation in Rheumatic Diseases.

Authors:  Norma Maugeri; Patrizia Rovere-Querini; Angelo A Manfredi
Journal:  Front Immunol       Date:  2016-05-19       Impact factor: 7.561

5.  Chromogranin-A production and fragmentation in patients with Takayasu arteritis.

Authors:  Enrico Tombetti; Barbara Colombo; Maria Chiara Di Chio; Silvia Sartorelli; Maurizio Papa; Annalaura Salerno; Enrica Paola Bozzolo; Elisabetta Tombolini; Giulia Benedetti; Claudia Godi; Chiara Lanzani; Patrizia Rovere-Querini; Alessandro Del Maschio; Alessandro Ambrosi; Francesco De Cobelli; Maria Grazia Sabbadini; Elena Baldissera; Angelo Corti; Angelo A Manfredi
Journal:  Arthritis Res Ther       Date:  2016-08-17       Impact factor: 5.156

Review 6.  Catestatin as a Target for Treatment of Inflammatory Diseases.

Authors:  Elke M Muntjewerff; Gina Dunkel; Mara J T Nicolasen; Sushil K Mahata; Geert van den Bogaart
Journal:  Front Immunol       Date:  2018-10-04       Impact factor: 7.561

7.  Serum catestatin levels in patients with rheumatoid arthritis.

Authors:  Petra Simac; Dijana Perkovic; Ivona Bozic; Marijana Matijas; Katarina Gugo; Dinko Martinovic; Josko Bozic
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.